menu

What do we need to know about bone marrow suppression from chemotherapy—and how can we manage these events?

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Breaking Down Bone Marrow Suppression

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Presenters
  • Sponsored by

  • Overview

    Dr. Jacob Sands, a Thoracic Medical Oncologist at the Dana-Farber Cancer Institute and an instructor of medicine at Harvard Medical School, shares insights on the pathophysiology of bone marrow suppression resulting from chemotherapy in small-cell lung cancer and explores how we can manage these myelosuppressive events.

Presenters
Recommended
Details
Presenters
  • Sponsored by

  • Overview

    Dr. Jacob Sands, a Thoracic Medical Oncologist at the Dana-Farber Cancer Institute and an instructor of medicine at Harvard Medical School, shares insights on the pathophysiology of bone marrow suppression resulting from chemotherapy in small-cell lung cancer and explores how we can manage these myelosuppressive events.

Presenters
Schedule16 Aug 2022
Webpack App